As of Nov 25
| +0.36 / +4.33%|
The 7 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 24.00 and a low estimate of 9.00. The median estimate represents a +72.81% increase from the last price of 8.68.
The current consensus among 8 polled investment analysts is to Buy stock in Infinity Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.